Organ support & nutrition

Acute skeletal muscle wasting in patients with acute kidney injury requiring continuous kidney replacement therapy: A prospective multicenter study

J Crit CarePublished Prospective observational cohort study

Authors' conclusion

Patients with AKI requiring CKRT experienced significant muscle wasting in the first week following CKRT initiation and had high rate of ICU-AW at hospital discharge.

Study context

Population
Critically ill adults with acute kidney injury (AKI) requiring continuous kidney replacement therapy (CKRT)
Participants
23 adults
Outcome
Changes in rectus femoris muscle mass and quality on ultrasonography
Follow-up
First week after CKRT initiation
Methodological detailsmulticentre, two ultrasonography (US) academic hospitals
  • Multicentre
  • Two US academic hospitals

Main finding

As reported in the abstract

Rectus femoris muscle changes, Day 1 to Day 7 · Day 1 to Day 7
Rectus femoris (RF) muscle thickness decrease, median [IQR]
10 % [3 %-20 %]
RF cross-sectional area decrease, median [IQR]
19 % [12 %-22 %]
Echo intensity increase (worse muscle quality), median [IQR]
14 % [5 %-25 %]
Effect of time, cross-sectional area (CSA)
F = 66.2, p < 0.001
Effect of time, muscle thickness
F = 27.1, p < 0.001
Effect of time, echo intensity
F = 22.5, p < 0.001

Observational data: associations, not effects.

Further findings

ICU-acquired weakness among survivors · hospital discharge

Survivors meeting intensive care unit-associated weakness (ICU-AW) criteria
67 % (n = 10/15)

ICU death

Died in ICU
Six (26 %)
Transitioned to comfort measures before study completion
one (4 %)

Original publication

Acute skeletal muscle wasting in patients with acute kidney injury requiring continuous kidney replacement therapy: A prospective multicenter study. J Crit Care. Published 12 June 2025. doi:10.1016/j.jcrc.2025.155142

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.